0.05 Versus 0.1 mg Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy
The Comparison of 0.05 vs. 0.1 Milligram Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy With/Without Anterior and Posterior Vaginoplasty
1 other identifier
interventional
72
1 country
1
Brief Summary
This study aims to compare the efficacy of 0.05 mg and 0.1 mg spinal morphine in reducing postoperative morphine requirement in patients undergoing vaginal hysterectomy with/without anterior and posterior vaginoplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4 pain
Started Mar 2010
Typical duration for phase_4 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 2, 2010
CompletedFirst Posted
Study publicly available on registry
March 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedSeptember 13, 2011
September 1, 2011
1.8 years
March 2, 2010
September 10, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The total amount of morphine that the patient required during the first 24-h postoperative.
24 hours
Study Arms (2)
Spinal morphine 0.05 mg
EXPERIMENTALPatient received spinal morphine 0.05 mg
Spinal morphine 0.1 mg
ACTIVE COMPARATORPatient received spinal morphine 0.1 mg
Interventions
Patient received spinal morphine 0.05 mg
Patient received spinal morphine 0.1 mg
Eligibility Criteria
You may qualify if:
- Female ASA physical status 1-3
- Undergoing vaginal hysterectomy with/without anterior and posterior vaginoplasty
- Be able to operate patient-controlled analgesia (PCA)
You may not qualify if:
- Allergy to the study drugs
- History of bleeding tendency
- Infection at the back
- Refuse to spinal anesthesia
- History of CAD or CVA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of medicine, Siriraj Hospital
Bangkok, 10700, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sirilak Suksompong, MD
Mahidol University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 2, 2010
First Posted
March 3, 2010
Study Start
March 1, 2010
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
September 13, 2011
Record last verified: 2011-09